SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Jones who wrote (1617)	9/14/1998 11:38:00 PM
From: Marvin Frank	Read Replies (1) of 4140

Latest news from ophthalmic journal praises SNRS laser procedure very highly with excellent results and NO side effects. The procedure is in phase III trials with need for 400 patients. This should be easy to accomplish since FDA approved bilateral treatment. Two articles seen in Ophthalmology Times this week by excellent researchers. I predict that the company should do well with this laser which is far less costly than the VISX instrument.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next